CLDX earnings date and last-quarter result: next report 2026-08-06, last quarter miss, P/E -8.14. Updated 2026-07-23.
Celldex Therapeutics (CLDX) Research Hub
Celldex Therapeutics (CLDX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 29.5 USD (+0.85%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -8.14, market cap 2.26B. This hub links to the full technical, earnings and options research available for CLDX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 29.5 USD (+0.85%) |
| 52-week range | 27.465 USD – 45.13 USD |
| Trend regime | Range |
| 14-day RSI | 43.4 (Bearish) |
| Trailing P/E | -8.14 |
| Market cap | 2.26B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for CLDX
Covered Call on CLDX: how it works, illustrative setup around the real 29.5 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CLDX: how it works, illustrative setup around the real 29.5 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CLDX: how it works, illustrative setup around the real 29.5 USD price, max profit/loss, breakeven and when to use it. Educational.
CLDX technical analysis: range, last 29.5 USD, RSI 43.4, 52w range 27.465 USD–45.13 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is CLDX in?
Celldex Therapeutics (CLDX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is CLDX in an uptrend or downtrend?
As of 2026-10-26, CLDX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CLDX's trailing P/E ratio?
CLDX's trailing P/E is -8.14, with a market cap of 2.26B. See the earnings research page for full valuation detail.
When does CLDX next report earnings?
CLDX is next scheduled to report earnings on 2026-08-06.